APRINOIA Therapeutics (APRI) – FDA
-
Apricus Biosciences (APRI) Reports Outcome of Vitaros End-of-Review Meeting FDA; Initiates Discussions with Interested Parties for U.S. Vitaros Rights
-
Apricus Biosciences (APRI) Announces Vitaros End-of-Review Meeting with FDA on April 12, 2018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to APRI Stock Lookup